Moore Alisoninsider trades
In SEC Form 4 filings, Moore Alison is listed as President and CEO of Codexis, Inc. (CDXS) and Director of Artiva Biotherapeutics, Inc. (ARTV). In the last 90 days, Moore Alison sold $8.6K of Codexis, Inc. (CDXS) on the open market and bought none.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-08
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CDXSCodexis, Inc. | Oct 12 | Oct 14 | S | 6,335 | $1.36 | Sale −$8,619 | 244,171 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.